Higher expression of IL13Rα1 was also presented as an indicator of poor prognosis of breast cancer [22], renal cell carcinoma [19], soft-tissue sarcomas [21], and glioblastoma [23]. Here, IL13RA1 is linked to soft tissue sarcoma.